Sapphiros Secures $12.4 Million BARDA Award to Advance Rapid Molecular Diagnostics for Biothreat Detection

Positive

AI Analysis

Summary

Sapphiros secured a multi-year $12.4 million BARDA award to develop disposable molecular diagnostic platforms for rapid biothreat detection in point-of-care and emergency response settings.

Importance:5/10

Sentiment:

0.70

government fundingmolecular diagnosticsbiothreat detectionpoint-of-careBARDA award

Related Companies

$MOLN $RTSL

Read the original article

Published by PR Newswire Clinical Trials on July 14, 2026 2:58 PM

Read Original